Anandamide induces apoptosis of PC-12 cells: involvement of superoxide and caspase-3  by Sarker, Krishna Pada et al.
Anandamide induces apoptosis of PC-12 cells:
involvement of superoxide and caspase-3
Krishna Pada Sarkera;*, Soichi Obarab, Masanori Nakataa, Isao Kitajimaa, Ikuro Maruyamaa
aDepartment of Laboratory and Molecular Medicine, Kagoshima University, Kagoshima-890, Japan
bDepartment of Neurosurgery, Faculty of Medicine, Kagoshima University, Kagoshima-890, Japan
Received 27 January 2000; received in revised form 13 March 2000
Edited by Masayuki Miyasaka
Abstract Anandamide (arachidonoylethanolamide), an endog-
enous cannabinoid receptor ligand has been suggested to have
physiological role in mammalian nervous system. However, little
is known about the role of anandamide on neuronal cells. Here,
we demonstrate that anandamide causes death of PC-12 cells,
showing marked DNA condensation and fragmentation, appear-
ance of cells at sub-G0/G1 and redistribution of phosphatidyl
serine, the hallmark features of apoptosis. Anandamide raised
intracellular superoxide level and CPP32-like protease activity in
PC-12 cells markedly. Furthermore, antioxidant N-acetyl
cysteine prevented anandamide-induced superoxide anion forma-
tion and cell death, implying that intracellular superoxide is a
novel mediator of anandamide-induced apoptosis of PC-12 cells.
z 2000 Federation of European Biochemical Societies.
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1. Introduction
Programmed cell death, or apoptosis, is a normal physio-
logical process that occurs during embryonic development, as
well as in the maintenance of tissue homeostasis. Neuronal
apoptosis is required for the development of the nervous sys-
tem but also occurs during pathophysiological states [1]. Ex-
tensive neuronal cell death is observed after acute brain in-
jury, including stroke [2] and trauma [3], is thought to
contribute to neurodegeneration diseases, such as Parkinson’s
disease and Alzheimer’s disease [4]. Additionally, neuronal
apoptosis is induced in response to agent that causes increase
in intracellular superoxide anion (O32) and resulting hydrogen
peroxide (H2O2). Antioxidant N-acetyl cysteine prevents neu-
ronal apoptosis induced by oxidative stress [5].
Anandamide, an arachidonic acid derivative has been iso-
lated and subsequently identi¢ed as endogenous cannabinoid
receptor ligand (CB), which is expressed abundant in brain [6].
Anandamide acts as a neuromodulator and may control in-
tercellular communication in astrocytes by regulating gap-
junction permeability [7,8]. Anandamide functions as a carrier
of arachidonic acid in the modulation of hepatic fatty acid
metabolism [9]. Anandamide hyperpolarizes the membrane
potential of the smooth muscle cells of endothelium-intact
arteries [10]. On the other hand, anandamide can be produced
rapidly from circulating blood cells, such as macrophage cell
line by lipopolysaccharide (LPS) during septic shock, and may
circulate in the blood [11]. Apart from this, anandamide re-
lease is also induced by platelet activating factor following
hemorrhagic shock [12]. Recently, we have shown that anan-
damide is one of the possible causative factors of hypotension
induced by endotoxin shock [13]. Administration of ananda-
mide into mice develops hypothermia, hypomotility and cata-
lepsy [14]. Anandamide exerts an immunoregulatory role in
the central nervous system [15]. Thus, our understanding
about the role of anandamide in pathophysiological state is
almost limited to the immune system. Hence, the role of anan-
damide on neuronal cells remains elusive. As anandamide can
be released and synthesized from macrophage, platelets and
endothelium, and can quickly reach to central nervous system
as well, we hypothesized synthesis and subsequent release of
anandamide can be enhanced in some pathophysiological
states in brain, such as stroke, cerebral hemorrhage or disrup-
tion of blood-brain barrier. In this study, we tested the e¡ects
of anandamide on rat pheochromocytoma (PC-12) cell line,
which has been suggested to be a useful model for neurobio-
logical and neurochemical studies [16]. Our data show for the
¢rst time that anandamide leads to the generation of intra-
cellular superoxide anion, which, in turn, triggers downstream
signals culminated to the caspase-3 activation, resulting in
apoptosis of PC-12 cells.
2. Materials and methods
2.1. Materials
Anandamide, propidium iodide (PI), superoxide dismutase (SOD),
N-acetyl cysteine (NAC), phorbol myristate acetate (PMA), cyto-
chrome c and RNAse were purchased from Sigma Chemicals Co.
(St. Louis, MO, USA). CPP32-like protease activity assay kit was
purchased from MBL (Nagoya, Japan), and 3-(4,5-dimethyl-2-thiazol-
yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) was bought from
Dojindo (Kumamoto, Japan). Win-102 (functionally active) and
Win-109 (functionally inactive) were purchased from Research Bio-
chemical Inc. (USA). Stock solution of anandamide (10 mM) was
prepared in ethanol, and stored in aliquots at 380‡C.
2.2. Cell culture
PC-12 cells were cultured in RPMI 1640 (Gibco BRL, USA) me-
dium supplemented with heat-inactivated at 56‡C 10% horse serum
and 5% fetal bovine serum (FBS) plus appropriate antibiotics at 37‡C
in the presence of 95% air and 5% CO2 in collagen coated dishes.
Human breast cancer cell line MCF-7 was maintained in Dulbecco’s
minimum essential medium (DMEM) (Gibco BRL, USA) containing
10% FBS.
2.3. Cell viability test
MTT assays were applied to test the cell viability. Brie£y, PC-12
cells were seeded at a density of 2.0^2.5U104 cells per well. PC-12
cells were treated with anandamide for the indicated concentrations
and periods. As anandamide was dissolved in ethanol, control cells
were incubated with the indicated percentage of ethanol. Following
the treatments, MTT (0.5 mg/ml ¢nal concentration) was added to
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each well, and incubation was then continued for 3 h. As mitochon-
drial enzyme converts MTT to insoluble formazon crystal, 100 Wl of a
solution containing 10% SDS (pH 4.8) plus 0.01 N HCl was added to
dissolve the crystal. Absorption values at 570^630 nm were deter-
mined with an automatic microtiter plate reader (Immuno Mini NJ-
2300, Japan).
Cell viability %  OD of the treated cellsU10
OD of the nonÿ treated cells
2.4. Propidium iodide staining
PC-12 cells were plated onto L-polylysine coated 2-well Lab-Tek
chamber (5U104/well), and stimulated with anandamide for the indi-
cated periods. After washing with phosphate-bu¡ered saline (PBS),
cells were permeabilized with acetone:methanol (1:1) for 10 min at
320‡C, and incubated with PI (10 Wg/ml) for 30 min at room temper-
ature in the dark. Apoptotic cells were analyzed with £uorescence
microscopy (Zeiss, Germany).
2.5. Analysis of cellular DNA content
For analysis of cellular DNA content, PI staining method was used.
Brie£y, PC-12 cells were plated at a density of 2.5U105 per 35 mm
dish. After treatment for the indicated periods, cells were extensively
washed with PBS, and centrifuged (200Ug for 5 min). The pellet was
resuspended in 70% ethanol (2 ml), and the suspension incubated at
320‡C for 20 min. Then cells were incubated for 15 min with PI
(5 Wg/ml) in PBS in the presence of RNase (5 Wg/ml). After that
DNA content was determined (2U104 cells each time) by FACS-can
analyzer (Epics, Coulter, USA).
2.6. Determination of phosphatidyl serine (PS) externalization by
FACS
To determine the externalization of PS, cells were washed in
DMEM twice and plated onto 60 mm dishes at a density of 1U106/
well in DMEM alone. Cells were treated with anandamide (10 WM)
for the indicated periods, harvested and incubated with annexin
V-FITC (Immunotech, France) according to the manufacturer’s in-
struction. Annexin V-positive cells were counted by the FACS-can
analyzer.
2.7. Assay of caspase activity
Cells plated in 10 cm dishes (2U106/dish) were treated with anan-
damide, and incubated for the times indicated in the ¢gure legends.
Following treatment, cells were washed, and lysed with chilled lysis
bu¡er (50 mM Tris^HCl (pH 7.4), 1 mM EDTA, 10 mM EGTA, and
10 WM digitonin) and incubated for 10 min on ice, followed by cen-
trifugation (15 000 rpm for 1 min). Then DEVDase activity was as-
sayed at 405 nm using DEVD-pNA as a substrate by a microplate
reader (ImmunoMini NJ-2300, Japan) in 96-well dish (Iwaki, Japan)
according to the manufacturer’s instructions. Fold increase in CPP32-
like protease activity was determined by comprising these results with
the level of uninduced control after subtracting the background read-
ings from lysates and bu¡ers from the readings of both induced and
uninduced samples.
2.8. Superoxide anion assay
Cytochrome c reduction method was used to measure the intra-
cellular superoxide by a slight modi¢cation of Pick et al. [17]. Brie£y,
cells (1U106/ml) were suspended in Hank’s balanced salt solution
containing cytochrome c (100 WM). From this cell suspension, 100 Wl
was incubated with anandamide (10 WM ¢nal concentration) in the
presence or absence of antioxidant agent SOD (300 U/ml) or NAC
(0.125^1 mM) at 37‡C for the indicated periods. Reaction mixture
without cells was used as a blank and PMA (10 WM) was used as a
positive control.
3. Results and discussion
3.1. Anandamide causes loss of cell viability of PC-12 cells
The rapidly accumulating data on anandamide demonstrate
that anandamide represents a new neurotransmitter system,
and plays a signi¢cant role in brain [18]. However, few studies
have been done on neuronal cells. In the present study, we
attempted to investigate the e¡ects of anandamide on PC-12
cells. Fig. 1B shows that in response to anandamide (10 WM)
cells rounded, phase became bright, and ¢nally detached from
the dish, indicating loss of viable cells in culture. Since cell
viability is positively correlated to the degree of MTT reduc-
tion, we then evaluated the cell viability of anandamide-
treated cells by using MTT reduction assays. Anandamide
dose-dependently caused the loss of cell viability of PC-12
cells. Fig. 1C shows that loss of cell viability was not observed
Fig. 1. Cytotoxic e¡ects of anandamide (ANA) on PC-12 cells. Cells
were plated in 6-well dishes at a density of 2U105/well. Following
an 18 h attachment, cells were incubated in the presence or absence
of ANA (10 WM) for 24 h. A: Control cells (0.01% ethanol).
B: Anandamide-treated cells. Representative photographs were also
taken at the same magni¢cation. Original magni¢cation, U200. For
determination of MTT reduction/cell viability, cells plated onto
96-well dishes were subjected to micromolar concentrations of anan-
damide for 24 h (C). D: Cells were incubated with micromolar con-
centrations of anandamide or Win-102 or Win-109 for 24 h. At the
end of this incubation, percentage of viable cells was counted by
MTT reduction assays as described in Section 2. Values are means
þ standard deviations (S.D.) of three independent experiments, in
triplicate.
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at a relatively low concentration of anandamide (6 7.5 WM).
However, a massive cell death has occurred when cells were
incubated with a higher concentration of anandamide. On
incubating the cells with anandamide (10 WM), cell viability
markedly decreased to 30 þ 3.6% of the control cultures (in the
presence of 0.01% ethanol) at 24 h after anandamide treat-
ment. Thus, it appears apparently that anandamide causes
death of PC-12 cells relatively at a higher concentration.
Anandamide (1 WM) vasodilates juxtamedullary a¡erent arte-
rioles perfused in vitro [19]. Anandamide, at a concentration
Fig. 2. Apoptotic features in anandamide-treated PC-12 cells. Cells were seeded onto Lab-Tek chambers treated with anandamide (10 WM) for
24 h. After this treatment, cells were stained with PI as described in Section 2. A: Control cells (0.01% ethanol). B: Anandamide-treated cells.
Experiments were done in duplicate and photographs were taken at the same magni¢cation. Original magni¢cation, U400. For analysis of cell
cycles, cells were treated with anandamide (10 WM) for 24 h. Cell cycles were analyzed with FACS-can analyzer as outlined in Section 2.
C: Control cells (0.01% ethanol). D: Anandamide (10 WM)-treated cells. E: Time course e¡ect of anandamide on PS externalization. Cells were
treated with anandamide (10 WM) for the indicated periods and PS externalization was determined with annexin V^FITC binding assay by £ow
cytometry (see Section 2). Similar experiments were done in duplicate.
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of 10 WM hyperpolarizes the membrane potential of the
smooth muscle cells of endothelium-intact arteries [10]. Ven-
ance et al. has reported that anandamide (10 WM) regulates
intercellular communication in astrocytes and non-glial cells
[8]. A question arises as to whether the used concentration of
anandamide in the present study is relevant to in vivo or not.
As anandamide is very unstable in vivo, the exact level of
anandamide in plasma/tissue remains to be de¢ned. Although
anandamide level in brain is lower than in either of adrenal,
lung, kidney or plasma but it reaches to the brain within a
minute [20]. Following endotoxin shock anandamide level in
plasma is elevated to 7.8-fold the normal concentration [21].
Anandamide level in serum has been found to be V500 nM
of a septic shock patient (our unpublished observation).
Hence, it might be considered as micromolar concentration
of anandamide in pathologic state(s).
Anandamide is an endogenous cannabinoid receptor ligand
and most of its cellular e¡ects are mediated through CB1
receptor activation in brain [6]. Recently, it has been shown
that delta 9-tetrahydrocannabinol (THC), the exogenous can-
nabinoid receptor ligand, causes apoptosis of hippocampal
neurons. At the same time, that THC-induced cell death has
been blocked by the CB1 receptor antagonist [22]. Therefore,
it is thought that cannabinoid receptor activation induces
apoptotic cell death. Hence, we sought whether cannabinoid
receptor activation could mimic anandamide’s e¡ect in PC-12
cells, which express CB1 receptor [23]. In parallel cultures, we
treated PC-12 cells with CB1 receptor agonist Win-102 (func-
tionally active) and Win-109 (functionally inactive). CB1 re-
ceptor activation pronounced signi¢cant cell death. Fig. 1D
shows that Win-102 dose-dependently evoked cytotoxic e¡ect,
resulting in marked cell death. Win-102, at a dose of 1 WM,
induced loss of cell viability to 29 þ 5.8%, however, Win-109,
at the same concentration (1 WM), aborted to exhibit the
cytotoxic e¡ect on PC-12 cells, indicating that the cytotoxic
e¡ect of anandamide is mediated through CB1 receptor acti-
vation. The ¢nding that CB1 receptor antagonist inhibits
apoptosis of hippocampal neurons induced by THC de¢nitely
favors our result [22].
3.2. Anandamide causes apoptosis of PC-12 cells
Cells die either following necrosis or apoptosis. Necrotic
cell death is regarded as accidental cell death, in which ¢rst
membrane is raptured, followed by the release of cytosolic
organelles, resulting in in£ammation. In contrast, apoptotic
cell death rather occurs in a controlled manner, where mor-
phological and biochemical changes are obvious. The mor-
phological changes, the ¢rst de¢ned apoptotic features, occur
in three phases [24]. In the ¢rst, there is condensation of
chromatin into crescentic caps at the nuclear periphery, nu-
cleolar disintegration, and reduction of nuclear size. There is
shrinkage of total cell volume, increase in cell density, com-
paction of cytoplasmic organelles, and dilation of endoplas-
mic reticulum but mitochondria remain morphologically nor-
mal. In phase 2 (which may overlap phase 1) there is budding
and separation of nucleus and cytoplasm into multiple, small,
membrane-bound apoptotic bodies, which may be shed from
epithelial surfaces or phagocytosed by neighboring cells or
macrophages [25]. In phase 3 there is progressive degeneration
of residual nuclear and cytoplasmic structures. Morphological
analysis of the anandamide-treated cells with PI staining dis-
played marked DNA condensation and fragmentation (Fig.
2B), demonstrating that anandamide leads to the PC-12 cells
undergoing apoptosis.
On the other hand, the biochemical features include appear-
ance of sub-diploid DNA (accumulation of cells at sub-G0/
G1) and redistribution of membrane phosphatidyl serine, a
phospholipid normally restricted to the inner lea£et of the
plasma membrane. It is conceived that phosphatidyl serine
is a membrane ‘£ag mark’ of apoptosis, appears on outer
membrane during early step of apoptosis, and helps macro-
phage or neighboring cells engulf apoptotic cell [26^29]. Thus,
the exposed membrane PS plays pivotal role in the elimination
of apoptotic cell before it exerts in£ammation. In agreement
with the DNA fragmentation result (Fig. 1B), cells having
diploid DNA gradually decreased, and subsequently frag-
mented DNA containing cells appeared notably at sub-G0/
G1. DNA content analysis indicated that about 56 and 19%
of the total cell population were at sub-G0/G1 (Fig. 2C,D) at
24 h in anandamide and control (0.01% ethanol) cultures,
respectively. These results indicate that anandamide causes
apoptosis of PC-12 cells.
Next, we looked for the appearance of phosphatidyl serine
on the outer membrane by annexin V^FITC binding assay.
Consistent with the results obtained from morphological
study, exposure of PS has occurred noticeably in ananda-
mide-treated cells. As shown in Fig. 2E, induction of PS ex-
Fig. 3. E¡ects of anandamide on superoxide anion production in
PC-12 cells. A: Time course e¡ects of anandamide on O32 forma-
tion. Cells were treated with anandamide (10 WM) for the indicated
periods and superoxide was assayed as described in Section 2.
B: Cells were incubated with anandamide in the presence or absence
of antioxidant agents for 1 h. The results are means þ S.D. of three
separate experiments.
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ternalization was started within 3 h that, in turn, signi¢cantly
increased at 6 h after anandamide addition. Flow cytometric
analysis indicates that annexin-positive cells were 45.2 and
12% in anandamide-treated and control (0.01% ethanol) cul-
tures, respectively, at 6 h onset of treatment. Taken together,
our results strongly suggest that anandamide induces apop-
totic death of PC-12 cells. Our ¢ndings are in line with the
previous report that anandamide causes inhibition of mitogen-
activated lymphocyte proliferation, and induces apoptosis
[30].
3.3. Anandamide causes superoxide anion formation in
PC-12 cells
Enhanced production of cellular superoxide or resulting
redox level takes part in the signal transduction pathway dur-
ing apoptosis induced by a wide variety of agents. Increased
level of superoxide anion (O32) or hydrogen peroxide (H2O2)
has been implicated in TNFK- and thrombin-induced cell
death [4,31]. Therefore, it tempted us to seek for the genera-
tion of superoxide anion in anandamide-treated PC-12 cells.
As shown in Fig. 3A, treatment of the PC-12 cells with anan-
damide resulted in a £ush of superoxide release in the extra-
cellular milieu as noted by the reduction of ferricytochrome c
to ferrocytochrome c by superoxide anion. The release of
superoxide anion was initiated within 15 min and reached
the peak at 1 h time point followed by progressive decrease.
Cellular superoxide or free radical can be scavenged by super-
oxide anion scavenger, such as SOD, an enzyme that catalyzes
the conversion of two of these radicals into hydrogen peroxide
and molecular oxygen (O2) (O32+O32 = H2O2+O2). Fig. 3B
shows that anandamide caused generation of superoxide
anion signi¢cantly, which, in turn, was abolished by the addi-
tion of SOD. Moreover, the superoxide production was in-
hibited by antioxidants like NAC, suggesting that superoxide
is regulating the downstream events of apoptosis in ananda-
mide-treated PC-12 cells.
3.4. N-acetyl cysteine prevents apoptotic death of
anandamide-induced PC-12 cells
Data presented in Fig. 3 support the speculation that intra-
cellular superoxide plays a critical role in anandamide-treated
cells. The possible involvement of superoxide or free radical in
anandamide-induced cell death was examined on incubating
the PC-12 cells with N-acetyl cysteine, which has been shown
to protect apoptosis induced by oxidative stress [32,33]. Next,
we extended our study to investigate if NAC could prevent
anandamide-induced cell death or not. If intracellular super-
oxide mediates anandamide-induced apoptosis, then antioxi-
dant NAC should block that cell death. As expected, NAC
concentration-dependently abrogated the anandamide-in-
duced cell death. Fig. 4 illustrates that a dose as low as
1 mM NAC that usually traps cellular H2O2, rescued the cells
as the viable cells increased markedly to 74.5 þ 2% of the
control cultures (without anandamide), establishing a de¢nite
link between anandamide-induced superoxide production and
cell destruction. This result is in agreement with the ¢nding
that NAC abrogates thrombin-induced Neuro-2a cell death
where intracellular superoxide or free radical has been attrib-
uted to the mediator of that cell death [4].
3.5. Anandamide induces CPP32-like protease activation in
PC-12 cells
It has been demonstrated that apoptosis may occur inde-
pendent of caspase activation [34,35], even though it is well
documented that cysteine protease caspase functions as a con-
verging point in apoptosis induced by di¡erent stimuli in var-
ious types of cells [36,37]. On the other hand, H2O2 causes the
activation of the intracellular death signaling protease cas-
pase-3 [38], conversely, it has been reported that caspase-3
induces the generation of hydrogen peroxide [39,40]. Hence,
it was of interest to clarify if the CPP32-like protease was
activated or not in anandamide-treated cells. Anandamide
led to the activation of CPP32-like protease activation in a
time-dependent manner in PC-12 cells. Fig. 5 shows that ac-
tivation of CPP32-like protease was initiated within 3 h,
which, in turn, was notably elevated (3.9-fold higher than
basal level) at 6 h after anandamide treatment, indicating
that CPP32-like protease is involved in anandamide-induced
PC-12 cell death. Recently, it has been unearthed that the
MCF-7 cell line lacks caspase-3 gene [41]. In order to reveal
that anandamide-induced apoptosis is dependent of caspase
activation, we took the advantage and treated the MCF-7
cells with anandamide. Consistent with the previous ¢nding
[42], we repeatedly observed that anandamide (10 WM) failed
to exert loss of cell viability of MCF-7 cells (data not shown).
Moreover, it is supported by the observation that sodium
nitropruside, at a dose that exhibits cytotoxic e¡ects in PC-
12 cells, does not a¡ect the viability of MCF-7 cells (Sarker,
Fig. 5. Activation of CPP32-like protease in PC-12 cells induced by
anandamide. Cells were plated onto 100 mm dishes (5U106/dish)
and treated with anandamide (10 WM) for the indicated periods.
CPP32-like protease activity was assayed as described in Section 2.
The data are means þ S.D. of three individual experiments.
Fig. 4. E¡ects of NAC on anandamide-induced apoptosis of PC-12
cells. Cells were plated onto 96-well plates. Indicated concentrations
of NAC were added 1 h prior to the addition of anandamide
(10 WM) and incubation was continued for 24 h. MTT reduction as-
says were done as described in Section 2. Results are given as
mean þ S.D. of the three independent experiments.
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unpublished). Hence, the inability of anandamide to a¡ect
viability of MCF-7 cells is likely to be attributed to the cas-
pase-3 de¢ciency in this cell line. Thus, our data conclude that
anandamide-induced cell death signaling converges to the cas-
pase-3 activation in PC-12 cells.
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